Cadence Bank grew its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 3.8% during the third quarter, HoldingsChannel reports. The firm owned 11,053 shares of the financial services provider’s stock after acquiring an additional 402 shares during the period. Cadence Bank’s holdings in MetLife were worth $912,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of MET. B. Riley Wealth Advisors Inc. lifted its stake in MetLife by 7.4% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 17,962 shares of the financial services provider’s stock worth $1,331,000 after purchasing an additional 1,230 shares in the last quarter. Tidal Investments LLC lifted its stake in MetLife by 45.9% in the 1st quarter. Tidal Investments LLC now owns 22,324 shares of the financial services provider’s stock worth $1,654,000 after purchasing an additional 7,024 shares in the last quarter. Sanibel Captiva Trust Company Inc. purchased a new position in MetLife in the 1st quarter worth approximately $279,000. Atria Investments Inc lifted its stake in MetLife by 6.2% in the 1st quarter. Atria Investments Inc now owns 60,805 shares of the financial services provider’s stock worth $4,506,000 after purchasing an additional 3,559 shares in the last quarter. Finally, Orleans Capital Management Corp LA raised its position in shares of MetLife by 50.8% during the 1st quarter. Orleans Capital Management Corp LA now owns 26,673 shares of the financial services provider’s stock valued at $1,977,000 after buying an additional 8,986 shares during the period. 89.81% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several analysts have recently commented on MET shares. Jefferies Financial Group lifted their price target on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Morgan Stanley reduced their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Piper Sandler lifted their price target on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research report on Monday. Finally, Wells Fargo & Company lifted their price target on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, MetLife has an average rating of “Buy” and a consensus target price of $88.62.
MetLife Stock Performance
NYSE:MET opened at $88.25 on Thursday. The company has a fifty day simple moving average of $83.05 and a two-hundred day simple moving average of $76.37. The company has a market cap of $61.11 billion, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 0.79 and a beta of 1.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 52 week low of $62.89 and a 52 week high of $89.05.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.47%. MetLife’s dividend payout ratio (DPR) is 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Using the MarketBeat Dividend Tax Calculator
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are the FAANG Stocks and Are They Good Investments?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.